- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Endocyte Inc+ Add to Watchlist
ECYT:US7.3599 USD 0.3799 5.44%
As of 20:10:00 ET on 08/29/2014.
Company Profile for Endocyte Inc (ECYT)
Endocyte Inc. is a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. The Company uses a proprietary technology to create small molecule drug conjugates, or SMDCs, and companion imaging diagnostics that actively target receptors that are over-expressed on diseased cells, relative to healthy cells.
Key Executives for Endocyte Inc (ECYT)
|P Ron EllisPresident/CEO/Co-Founder||Michael A ShermanCFO/COO|
|Philip S LowChief Science Officer||Binh NguyenVP:Medical Affairs|
|Christopher P LeamonVP:Research||Michael A BrinkleyVP:Quality|
|Scot L Harper "Scot"VP:Clinical Operations||Chandra D LovejoyVP:Regulatory Affairs|
|Allen R RitterVP:Manufacturing||Beth A TaylorController|